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Synthesis of ellagic acid and its 4,4'-di-O-alky derivatives from gallic acid
Ashraful Alam,a,b Yutaka Takaguchia and Sadao Tsuboia,*
(Received November 29, 2004)
Synthesis ofellagic acid and its 4,4'-di-O-alkyl derivatives from gallic acid is described.
Ellagic acid is prepared by oxidative coupling of gallic acid with o-chloranil.
Functionalized methyl bormogallate underwent Ullmann coupling to give the biphenyl
that upon lactonization resulted in the ellagic acid and its alkoxy derivatives.
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Introduction
Ellagic acid and its derivatives are very potent for
their various biological activities such as
anti-tumor, I anti-HIV,2 anti-cancer,3 anti-hepa-
titis,4 anti-oxidant5 and anti-microbial6 effects.
Interestingly ellagic acid and its derivatives
exhibit free radical scavenging activity and thus
used in anti-aging supplements.7 Takasaki8 has
reported the isolation of variety of ellagic acid
derivatives and their inhibitory effects on
Epstein-Barr virus action. They found the
enhanced inhibitory activity of some ellagic acid
derivatives than the parent compound ellagic acid.
Other di- or trialkoxy derivatives (Fig. 1) also
found to be much more active than the ellagic
acid itself. Besides the wide biological activity of
ellagic acid and its derivatives, these are used as
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important ingredients for some supliments such
as anti-aging, skin lightening and other skin care
cosmetics.9 Recent study revealed that the ellagic
acid prevent the breast cancer and base on this,
some oral medicines or medicated creams
containing ellagic acid are commercially
available. 10
Fig. 1 Ellagic acid and its 4,4'-di-O- derivatives.
R1=R3=H, R2=R4= OMe;
4,4'-di-0-methylellagic, 12a
R1=R3=H, R2=~= 08n;
4,4'-di-O-benzylellagic, 12b
High concentration of Ellagic acid occurs in
raspberries, strawberries, cranberries, grapes,
berries, nuts such as walnuts, pecans, etc and
these are good sources for the dietary
requirements of ellagic acid. In plants, it is
present in the form of esters of glucose with
hexahydroxydiphenic acid, called ellagitannin.
When hydrolyzed, ellagitannin yields ellagic acid,
and this method of hydrolysis is one of the major
sources of ellagic acid. On the other hand all the
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ellagic acid derivatives investigated so far either
has been isolated from the plants materials or
derivatized from ellagic acid.4(b),8,1l Commercial
ellagic acid is provided by hydrolysis of natural
ellagitannins. However, recently the synthesis of
ellagic acid has been reported. 1Z
Here we wish to report a simple method for the
systematic synthesis of ellagic acid, 4,4'-di-O-
methylellagic acid 12a and 4,4'-di-O-benzyl-
ellagic acid 12b from the cheap and
commercially available gallic acid. This method
can also be applied for the synthesis of other
4,4'-di-O-derivative as well as other tri-O-
derivatives of ellagic acid.
Results and discussion
Commercially available gallic acid 1 was
esterified to methyl gallate 2 by treating it with
methanol in the presence of HzS04. Methyl
gallate 2 was treated with oxidizing agent
o-chloranil at -40°C to room temperature
followed by the reduction with NaZSZ04 gave the
hexahydroxy diphenyl 4. 13 Compound 4 was
refluxed with MeOHlHzO (l :I) resulted in
lactonization13 and gave the desired ellagic acid 5
in high yield (Scheme I).
Unlike most of the reported methods mentioned
before, we started the synthesis of
4,4'-di-O-alkylellagic acid from gallic acid 1
(Scheme 2). For this purpose methyl gallate 2
was converted to methyl 3-methoxy-4,5-
dihydroxybenzoate 7a via acetal 6 in 99% yield
over 2 steps. Similarly, methyl 3-benzyloxy-4,5-
dihydroxybenzoate 7b was also prepared in
almost 100% yield from 6. Regioselective
bromination of 7a and 7b at 6-position was done
by our DBDMH method,14 which gave the
corresponding bromides 8a and 8b respectively.
The hydroxy groups of 8a and 8b were protected
as acetals 9a and 9b respectively. Then, the fully
hydroxy protected methyl bromogallate 9a and
9b underwent the Ullmann coupling reaction to
give the desired key intermediate lOa and lOb in
40 and 70% yield respectively. Deprotection of
lOa and lOb gave the tetrahydroxybiphenyl lla
and llb in 98% ofyield.
Scheme 1. Preparation ofellagic acid by oxidative coupling of gallic acid
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Lactonization of compounds lla and llb by
refluxing with MeOH/H20 (I: I) gave the
quantitative yield of desired ellagic acid
derivatives 4,4'-di-O-methylellagic acid 12a and
4,4'-di-O-benzylellagic acid 12b respectively.
Scheme 2. Preparation of4,4'-di-O-alkylellagic acid from gallic acid by Ullmann coupling
o OMe ~OOMe~ (EtObCH,I ~ Amberlyst 15E. I ":::HO .0 OH benzene, O.b- OHOH reflux, 18h EtO~O
2 6,99%
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Experimental
General: All moisture-sensitive reactions were
carried out under nitrogen atmosphere using
oven-dried glassware. Solvents were dried over
standard drying agents. Reactions were
monitored on TLC on silica gel 60 F254 and
visualized under UV light and/or 5% ethanolic
solution of phosphomolybdic acid. Flash
chromatography was performed on silica gel
(Merck, 60N, spherical, neutral, 40-50 mash).
Melting points were determined with a
Mel-TEMP apparatus. IR was recorded on a
Thermo Nicolet Avatar 360T2 instrument using
ATR. 'H NMR (300 MHz) and BC NMR (75
MHz) were recorded by JEOL AL 300 instrument.
GC-MS was studied with a SHIMADZU GCMS-
QP5000 instrument.
Methyl gallate (2): To a 200 ml round bottom
flask fitted with a condenser was added gallic
acid 1 (6.00 g, 10.8 mmol), dry MeOH (120 ml)
and cone. H2S04 (1.20 g), and then the mixture
was heated at retluxing temperature for 6-8 h.
After completion of the reaction, the solvent was
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removed in vacou and extracted with EtOAc
followed by washing with sufficient amount of
water. The organic layer was concentrated in
vacou giving the crude methyl gallate 2.
Recrystallization from hot water gave 6.36 g of
pure methyl gallate (99%).
Dimethyl 4,4',5,5',6,6'-hexahydroxybiphenyl-
2,2'-dicarboylate (4): Solution of 2 (1.70 g, 9.24
mmol) in Et20 (90ml) was added dropwise under
argon to a stirred cooled solution of o-chloranil
(2.49 g, 10.1 mmol) in Et20 (20ml) at -40°c.
After completion of the addition, the reaction
mixture was allowed to warm slowly to rt. over 2
hour and an additional 1h and was stirred at rt.
The yellow solid was appeared at the bottom of
the flask and separated by filtration. The solid
was washed extensively with cooled Et20 to give
a yellow solid (1.28 g). The yellow solid was
dissolved in THF and solution was cooled to O°C
and Na2S204 (1.22 g) was added. The solution
was stirred at rt for 30 min, poured in ice-cooled
water and the organic layer was extracted with
Et20. Removal of the solvent gave the crude
hexahydroxydiphenyl 4: mp 240-245°C(decomp.).
IH NMR (CDCh- CD30D) 8 3.46 (s, 6H), 7.12 (s,
2H), 7.66 (bs, 6H); 13C NMR (CDCh-CD30D) 8
51.33, 110.70, 118.73, 122.55, 137.53, 144.52,
144.65.
Ellagic acid (5): Compound 4 (260 mg) was
refluxed in MeOH:H20 (1: 1, 5ml) for 18 h
resulted in lactonization. Complete removal of
the solvent yielded the crude ellagic acid 5 (218
mg, 100%) which was recrystallized from
DMSO/CHCh (1: 1) to give a light brown solid:
mp 350"C; IR: 3572, 3066, 1690, 1616, 1581,
1446, 1396, 1326, 1195, III 0, 1053, 922, 882,
756 cm,l (identical with the authentic ellagic
acid). Anal. Calcd for CI4H60: C, 55.64; H, 2.00;
Found: C, 55.52; H, 2.11.
Methyl-3-hydroxy-4,5-(ethoxymethylenedioxy)
benzoate (6): A mixture of compound 2 (2.50 g,
13.6 mmol), (EtO)3CH (6.03 g, 40.7 mmol) and
Amberlyst 15E (62 mg) in benzene (140 ml) was
refluxed for 18 h with azeotropic removal of the
EtOH:benzene mixture by using the Dean Stark
trap. After completion, the reaction mixture was
filtered over celite and the solvent was removed
and directly put on a silica gel column eluted with
10-15% EtOAc in hexane yielded 3.21 g of 6
(99%) as a white solid: mp 91-92°C; IR: 3351,
1709, 1618, 1438, 1316, 1254, 1081, 1038, 765
cm,l; IH NMR (CDCh) 8 1.28 (t, 3H, J= 7.1 Hz),
3.75 (q, 2H, J= 7.1 Hz), 3.88 (s, 3H), 5.56 (bs,
IH),6.96(s, IH), 7.19 (d, IH, J= 1.5 Hz), 7.39 (d,
IH, J= 1.8 Hz); l3C NMR (CDCh) 8 14.68,52.38,
59.71, 102.71, 113.96, 120.04, 124.03, 137.08,
138.68, 147.14, 166.95.
Methyl 3-methoxy-4,5-dihydroxybenzoate(7a):
Compound 6a was treated with Mel (1.2 eq),
K2C03 (2.0 eq.) in DMF at 55-60"C for 12 h.
Then the crude was extracted with Et20, washed
with brine, dried over MgS04and concentrated.
The crude was treated with 2N aq.HCI at rt. for 2
h in MeOH gave 7a (99% yield over 2 steps) as a
colorless crystal: mp 115-119°C; IR: 3382, 1708,
1593, 1506, 1436, 1243, 1161, 1058, 1000,964,
726 cm'l; IH NMR (CDCh) 8 3.88 (s, 3H), 3.92
(s, 3H), 5.49 (s, IH), 5.86 (s, 1H), 7.21 (d, IH, J=
1.8 Hz), 7.34 (d, IH, J= 1.8 Hz); l3C NMR
(CDCh- CD30D) 8 51.85, 55.96, 104.94, 110.78,
120.38,138.51, 144.21, 147.18, 167.56.
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Methyl 3-benzyloxy-4,5-dihydroxybenzoate
(7b): Using a similar procedure of 7a with
BnCI instead of Mel compound 7b was obtained
in ~100% yield as a colorless solid: mp
142-145°C; lR: 3412, 3342, 1686, 1434, 1326,
1239, 1055,744 em-I; IH NMR (CDCh) 8 3.87 (s,
3H), 5.14 (s, 2H), 5.36 (s, IH), 5.84 (s, IH), 7.31
(d, lH, J= 1.8 Hz), 7.35 (d, IH, J= 1.8 Hz),
7.39-7.43 (m, 5H); l3C NMR (CDCh-CD30D) 8
51.76, 71.03, 106.36, 110.92, 120.36, 127.71,
128.06, 128.38, 136.08, 138.62, 144.33, 167.33
Methyl 2-bromo-3,4-dihydroxy-5-methoxyben-
zoate (8a): Using the procedure of ref. 14, 8a
was prepared form 7a in 98% yield as a slight
yellow crystal: mp 140-142°C; lR: 3461, 3341,
1717, 1601, 1429, 1292, 1210, 1101, 1018,923,
776 em-I; IH NMR (CDCh) 8 3.91 (s, 3H), 3.94
(s, 3H), 5.84 (s, IH), 5.92 (s, lH), 7.18 (s, IH);
l3C NMR (CDCh) 8 52.30,56.42, 103.26, 107.06,
121.81, 136.68, 141.36, 145.67, 165.94.
Methyl 2-bromo-3,4-dihydroxy-5-benzoxyben-
zoate (8b): Using the same procedure of 8a, 8b
was prepared from 7b in 95% yield as a light
yellow crystal: mp 116-118"C; lR : 3370, 1712,
1342, 1222, 1000 em-I; IH NMR (CDCh) 8 3.90
(s, 3H), 5.14 (s, 2H), 5.91 (s, IH), 5.92 (s, IH),
7.27 (s, 1H), 7.38-7.52 (m, 5H); l3C NMR
(CDCh- CD30D) 8 52.14, 71.34,103.24, 108.31,
121.44, 127.96, 128.45, 128.62, 133.74, 137.64,
142.61, 144.93, 167.37.
Methyl 2-bromo-3,4-(ethoxymethylenedioxy)-
5-methoxybenzoate (9a): Using the similar
procedure as compound 6, compound 9a was
prepared in 69% yield from 8a as a white solid:
mp 80-81°C; lR: 1722, 1432, 1318, 1171, 1081,
1035, 938, 752, 700 em-I; 'H NMR (CDCh) 8
1.28 (t, 3H, J= 7.1 Hz), 3.73 (q, 2H, J= 7.1 Hz),
3.91 (s, 3H), 3.94 (s, 3H), 7.01 (s, IH); 13C NMR
(CDCh) 8 14.68, 52.28, 59.85, 71.79, 94.16,
114.41,119.91, 124.17, 127.65, 128.32, 128.59,
135.90, 137.24, 140.43, 146.57, 165.41.
Methyl 2-bromo-3,4-(ethoxymethylenedioxy)-
5-benzoxybenzoate (9b): Using the similar
procedure of 9a, 9b was prepared in 66% yield
from 8b as a light yellow crystal: mp 116-118°C;
lR: 3370, 1712, 1342, 1222, 1000 cm-\ IH NMR
(CDCh) 8 3.90 (s, 3H), 5.14 (s, 2H), 5.91 (s, IH),
5.92 (s, IH), 7.27 (s, 1H), 7.38-7.52 (m, 5H); 13C
NMR (CDCh-CD30D) 8 52.14, 71.34, 103.24,
108.31, 121.44, 127.96, 128.45, 128.62, 133.74,
137.64, 142.61, 144.93, 167.37.
Dimethyl 4,4'-dimethoxy-5,6,5',6'-bis(ethoxymeth
lenedioxy)biphenyl-2,2'-dicarboxylate (lOa): A
mixture of compound 9a (655 mg), Cu powder
(655 mg) and DMF (1.5 ml) was stirred at 110°C
for 3h. Then another 10 ml of DMF was added
and the reaction mixture was stirred at 180°C for
18 h. After completion, crashed ice was added
and extracted with CHCh. The organic layer was
washed with water and then brine, dried over
MgS04 and concentrated in vacou. Purification
by silica gel column chromatography (eluted with
20% EtOAc in hexane and then 100% CHCh)
gave 155 mg of lOa (40%). White solid, IH NMR
(CDCh) 8 1.28 (1, 6H, J= 7.1 Hz), 3.73 (q, 4H, J=
7.1 Hz), 3.84 (s, 6H), 4.00 (s, 3H), 4.03 (s, 3H),
6.89 (s, 2H).
Dimethtl 4,4'-dibenzoxy-5,6,5',6'-bis(ethoxymeth
ylenedioxy)biphenyl-2,2'-dicarboxylate (lOb):
Using the same procedure as lOa, lOb was
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obtained in 70% from 9b as gummy solid. IR:
2979, 1724, 1638, 1589, 1433, 1348, 1314, 1243,
1171, 1091, 1036, 906, 746, 698. IH NMR
(CDCh) 01.28 (t, 6H, J= 7.1 Hz), 3.73 (q, 4H, J=
7.1 Hz), 3.60 (s, 6H), 5.24 (s, 4H), 7.34--7.49 (m,
12H); l3C NMR (CDCh) 0 14.13, 14.56, 14.65,
14.68, 51.76, 51.85, 58.27, 58.66, 58.72, 58.93,
71.48, 111.29, 111.61, 111.87, 112.59, 112.66,
112.71, 112.76, 119.63, 119.70, 119.73, 119.87,
123.05, 123.21, 123.41, 123.63, 127.73, 128.18,
128.54, 128.66, 128.68, 136.27, 136.97, 137.09,
137.14, 140.58, 140.69, 140.75, 140.82, 145.70,
145.75, 166.21, 166.23, 166.25.
Dimethyl 5,5',6,6'-tetrahydroxy-4,4'-dimethoxy
biphenyl-2,2'-dicarboxylate (11a): Treatment of
lOa with 2N HCI in MeOH at room temperature
for 4 h gave the hexahydroxy biphenyl 11a in
98% yield. White solid, IH NMR
(CDCh-CD30D) 0 3.63 (s, 6H), 3.75 (s, 6H),
5.30 (s, 2H), 5.89 (s, 2H), 7.42 (s, 2H).
Dimethyl 5,5',6,6'-tetrahydroxy-4,4'-dibenzoxy
biphenyl-2,2'-dicarboxylate (11b):Using the
same procedure as 11a, 11b was also prepared in
98% yield from lOb. IR: 3232, 1701, 1617, 1572,
1497, 1444, 1371, 1338, 1255, 1186, 1126, 1089,
810, 757, 740, 695. IH NMR (CDCh) 0 3.63 (s,
6H), 5.18 (s, 4H), 5.30 (s, 2H), 5.89 (s, 2H),
7.40~7.46 (s, 1H), 7.38-7.52 (m, 12H); l3C NMR
(CDCh) 8 51.86, 71.26, 107.00, 1l9.09, 121.30,
128.22, 128.53, 128.74, 133.95, 136.58, 141.72,
144.97, 166.74.
4,4'-Di-O-methylellagic acid (12a): Compound
11a was dissolved in MeOWH20 (1:1) and was
refluxing at 1100e for 8 h gave the final product
12a in almost quantitative yield. Light brown
solid: mp 358-361°C(decomp) (lit. IS 360-363); IH
NMR (CDCh- DMSO-D6) 0 4.00 (s, 6H), 7.57 (s,
2H), 7.85 (s, 2H).
4,4'-Di-O-benzylellagic acid (12b): Using the
similar procedure as 12a, 12b was prepared in
quantitative yield. Light yellow solid, mp
280-285 "C (decomp); IH NMR (CDCh-
DMSO-D6) 0 5.31 (s, 4H), 7.35~7.45 (m, 6H),
7.51-7.55 (m, 4H), 7.66 (s, 2H), 7.92 (s, 2H).
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